# Proviral DNA as a Target for HIV-1 Resistance Analysis

> **NCT04088916** · — · UNKNOWN · sponsor: **University of Chile** · enrollment: 1200 (estimated)

## Conditions studied

- HIV/AIDS
- HIV Infections
- HIV Seropositivity
- Viral Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04088916
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-15
- **Primary completion:** 2019-09-08
- **Final completion:** 2022-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088916, "Proviral DNA as a Target for HIV-1 Resistance Analysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04088916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*